blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4182306

EP4182306 - 4-FURANAMIDES AND METHOD FOR THE PRODUCTION THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  21.04.2023
Database last updated on 13.07.2024
FormerThe international publication has been made
Status updated on  21.01.2022
Formerunknown
Status updated on  23.07.2021
Most recent event   Tooltip26.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
51373 Leverkusen / DE
[2023/21]
Inventor(s)01 / HÖMBERGER, Günter
65817 Eppstein / DE
02 / REMBIAK, Andreas
65812 Bad Soden / DE
 [2023/21]
Representative(s)BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 50
40789 Monheim am Rhein / DE
[2023/21]
Application number, filing date21740006.802.07.2021
[2023/21]
WO2021EP68287
Priority number, dateEP2020018613816.07.2020         Original published format: EP 20186138
[2023/21]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2022012963
Date:20.01.2022
Language:DE
[2022/03]
Type: A1 Application with search report 
No.:EP4182306
Date:24.05.2023
Language:DE
The application published by WIPO in one of the EPO official languages on 20.01.2022 takes the place of the publication of the European patent application.
[2023/21]
Search report(s)International search report - published on:EP20.01.2022
ClassificationIPC:C07D307/68
[2023/21]
CPC:
C07D307/68 (EP,IL); C07D307/56 (US); Y02P20/55 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/21]
TitleGerman:4-FURANAMIDE UND VERFAHREN ZU DEREN HERSTELLUNG[2023/21]
English:4-FURANAMIDES AND METHOD FOR THE PRODUCTION THEREOF[2023/21]
French:4-FURANAMIDES ET LEUR PROCÉDÉ DE PRODUCTION[2023/21]
Entry into regional phase16.02.2023National basic fee paid 
16.02.2023Designation fee(s) paid 
16.02.2023Examination fee paid 
Examination procedure16.02.2023Examination requested  [2023/21]
16.02.2023Date on which the examining division has become responsible
23.08.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
29.06.2023Renewal fee patent year 03
26.06.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO2018228985  (BAYER AG [DE], et al) [AD] 1-6 * example - * * claim - * * page 10 ** page 21 *;
 [YD]  - FEDERICO BRUCOLI ET AL, "Efficient synthesis and biological evaluation of proximicins A, B and C", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER, NL, vol. 20, no. 6, doi:10.1016/J.BMC.2012.01.043, ISSN 0968-0896, (20120126), pages 2019 - 2024, (20120204), XP028465313 [YD] 1-6 * abstract * * Schema 2;; compound 15 * * page 2022 - column 2 *

DOI:   http://dx.doi.org/10.1016/j.bmc.2012.01.043
 [YD]  - CUILING WANG ET AL, "Synthesis of Imatinib by C-N Coupling Reaction of Primary Amide and Bromo-Substituted Pyrimidine Amine", ORGANIC PROCESS RESEARCH & DEVELOPMENT, US, (20190920), vol. 23, no. 9, doi:10.1021/acs.oprd.9b00227, ISSN 1083-6160, pages 1918 - 1925, XP055753518 [YD] 1-6 * abstract * * Schema 4 *

DOI:   http://dx.doi.org/10.1021/acs.oprd.9b00227
by applicantWO2018228985
    - CRAIG et al., Bioorganic & Medicinal Chemistry Letters, (20020000), vol. 12, no. 18, pages 2647 - 2650
    - F. BRUCOLI et al., Bioorganic & Medicinal Chemistry, (20120000), vol. 20, no. 6, pages 2019 - 2024
    - SPEROTTO, Dalton Trans., (20100000), vol. 39, pages 10338 - 10351
    - JI et al., J. Org. Chem., (20120000), vol. 77, page 7471
    - WANG et al., Org. Process Res. Dev., (20190000), vol. 23, page 1918
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.